The BSV family history risk assessment tool uses the information women provide on their family history of breast and ovarian cancer. It does not include all risk factors for breast cancer. Other factors may increase or decrease a woman's risk of developing breast cancer. It is important women are aware of this and discuss their possible increased risk of breast cancer further with their GP if concerned.
More information: Family history of breast cancer, information for GPs
Women diagnosed with some benign (non-cancerous) breast conditions have a higher risk of developing breast cancer. These include:
Lobular carcinoma in situ (LCIS)
Atypical ductal hyperplasias (ADH)
Atypical lobular hyperplasia (ALH)
Women diagnosed with these benign breast conditions are eligible for annual screening. They are strongly encouraged to see their GP for annual clinical evaluation.
More information: Lobular carcinoma in situ and atypical hyperplasias of the breast.
Women diagnosed with breast cancer or DCIS more than five years ago are able to have annual breast screens with BreastScreen Victoria with the approval of their treating doctor. These women are not automatically re-invited to join the Program; they must re-enrol. Only women with mammographic abnormalities will be recalled for further tests. All other women will be advised to see their GP for clinical examination.
More information: Women with a previous diagnosis of breast cancer fact sheet.
Breasts are made up of a mixture of fibrous and glandular tissue and fatty tissue. Your breasts are considered dense if you have a lot of fibrous or glandular tissue but not much fat.
Australian and international researchers have been investigating breast density for many years but there is currently no consistent way to measure it.
BreastScreen Australia supports research, greater discussion, and public awareness of breast density, and has released a Position Statement on breast density and screening.
The Royal Australian and New Zealand College of Radiologists has also released a Postion Statement on breast density.
Breast tomosynthesis (3D mammography) has been approved by the Australian Therapeutic Goods Administration for screening and diagnosis of breast cancer.
Evidence indicates 3D mammography may improve diagnostic accuracy in the early detection of breast cancer. However, there is limited data on the impact of 3D mamamography when used prospectively in population screening environments.
This is an evidence-based educational module designed to support the central role that GPs play in discussing and managing cancer screening, including providing evidence-based information to patients so they can make an informed choice about participation in screening.
Guidelines for preventative activities in general practice.
Cancer Council Victoria is a non-profit cancer charity organisation involved in cancer research, patient support, cancer prevention and advocacy.
BreaCan is an information and support service for people affected by a gynaecological cancer or breast cancer, their families and friends.
A national government agency working to reduce the impact of cancer on all Australians. Provides information on the disease, research and clinical trials.
Breast Cancer Network Australia (BCNA) works to ensure that women diagnosed with breast cancer, and their families, receive the very best information, treatment, care and support possible.
The leading community-funded organisation in Australia raising money for research into the prevention, detection and treatment of breast cancer.